KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Photronics (PLAB) Cash & Equivalents (2016 - 2026)

Photronics has reported Cash & Equivalents over the past 17 years, most recently at $544.1 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 15.27% year-over-year to $544.1 million; the TTM value through Feb 2026 reached $544.1 million, down 15.27%, while the annual FY2025 figure was $492.3 million, 17.75% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $544.1 million at Photronics, up from $492.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $642.2 million in Q1 2025 and troughed at $314.2 million in Q1 2022.
  • A 5-year average of $460.2 million and a median of $492.3 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 54.86% in 2023 and later dropped 17.75% in 2025.
  • Year by year, Cash & Equivalents stood at $322.4 million in 2022, then surged by 54.86% to $499.3 million in 2023, then increased by 19.87% to $598.5 million in 2024, then decreased by 17.75% to $492.3 million in 2025, then grew by 10.54% to $544.1 million in 2026.
  • Business Quant data shows Cash & Equivalents for PLAB at $544.1 million in Q1 2026, $492.3 million in Q4 2025, and $479.5 million in Q3 2025.